NEW YORK (GenomeWeb News) — Affymetrix today launched its Drug Metabolizing Enzymes and Transporters early-access service program and announced that two units of Clinical Data would provide the services worldwide.
 
Affymetrix is initially launching the pharmacogenomics DMET panel as a service, which also is available through its clinical lab service in South San Francisco. The firm has said that it intends to offer the DMET panel as a catalogue product this year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.